# Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)

Study · id `cardio:ct-nct02035644` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02035644](<https://clinicaltrials.gov/study/NCT02035644>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02035644

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

## Technical summary

Registry record NCT02035644. Randomized; double masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2015-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 360 participants (planned count; ClinicalTrials.gov record NCT02035644, source copy `cardio:ctgov-nct02035644-2014-01-14`, retrieved 2026-10-26)
- Start date: 2014-02 (registry gives no type) (ClinicalTrials.gov record NCT02035644, source copy `cardio:ctgov-nct02035644-2014-01-14`, retrieved 2026-10-26)
- Primary completion: 2015-02 (anticipated) (ClinicalTrials.gov record NCT02035644, source copy `cardio:ctgov-nct02035644-2014-01-14`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT02035644, source copy `cardio:ctgov-nct02035644-2014-01-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02035644-2014-01-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)
- Condition: Type 2 Diabetes
- Condition: Dyslipidemia
- Intervention (Drug): Jinlida granules
- Intervention (Drug): placebo granules
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER
- Collaborator: Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)
- Registry lists this organization as a collaborator: Shijiazhuang Yiling Pharmaceutical Co. Ltd (`cardio:org-shijiazhuang-yiling-pharmaceutical-co-ltd`)

## Provenance

Content hash: 5198ab9fcd56070d309812e16b20d2e2bd2c0ac6750c2fdeaca2b5763b9fe33e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
